Adriamycin plus vincristine compared to and combined with cyclophosphamide, methotrexate, and 5-fluorouracil for advanced breast cancer (Q66912724)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1116104%20AND%20SRC:MED&resulttype=core&format=json

31 August 2019

title

Adriamycin plus vincristine compared to and combined with cyclophosphamide, methotrexate, and 5-fluorouracil for advanced breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1116104%20AND%20SRC:MED&resulttype=core&format=json

31 August 2019

1 reference

1 reference

1 reference

1 reference

1 reference

10.1002/1097-0142(197504)35:4<1108::AID-CNCR2820350414>3.0.CO;2-Z

https://api.crossref.org/works/10.1002/1097-0142(197504)35:4%3C1108::AID-CNCR2820350414%3E3.0.CO;2-Z

29 September 2023

author name string

M. De Lena

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1116104

23 August 2022

C. Brambilla

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1116104

23 August 2022

A. Morabito

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1116104

23 August 2022

G. Bonadonna

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1116104

23 August 2022

language of work or name

English

0 references

publication date

1 April 1975

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1116104%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

31 August 2019

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197504)35:4%3C1108::AID-CNCR2820350414%3E3.0.CO;2-Z

1 reference

10.1002/1097-0142(197504)35:4<1108::AID-CNCR2820350414>3.0.CO;2-Z

https://api.crossref.org/works/10.1002/1097-0142(197504)35:4%3C1108::AID-CNCR2820350414%3E3.0.CO;2-Z

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197504)35:4%3C1108::AID-CNCR2820350414%3E3.0.CO;2-Z

29 September 2023

1 reference

10.1002/1097-0142(197504)35:4<1108::AID-CNCR2820350414>3.0.CO;2-Z

https://api.crossref.org/works/10.1002/1097-0142(197504)35:4%3C1108::AID-CNCR2820350414%3E3.0.CO;2-Z

29 September 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1116104%20AND%20SRC:MED&resulttype=core&format=json

31 August 2019

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1116104%20AND%20SRC:MED&resulttype=core&format=json

31 August 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1116104%20AND%20SRC:MED&resulttype=core&format=json

31 August 2019

page(s)

1108-1115

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1116104%20AND%20SRC:MED&resulttype=core&format=json

31 August 2019

1

15

100

Ahmann

1974

1 reference

10.1002/1097-0142(197504)35:4<1108::AID-CNCR2820350414>3.0.CO;2-Z

https://api.crossref.org/works/10.1002/1097-0142(197504)35:4%3C1108::AID-CNCR2820350414%3E3.0.CO;2-Z

Cyclical Combination Chemotherapy for Advanced Breast Carcinoma

29 September 2023

6

1 reference

10.1002/1097-0142(197504)35:4<1108::AID-CNCR2820350414>3.0.CO;2-Z

https://api.crossref.org/works/10.1002/1097-0142(197504)35:4%3C1108::AID-CNCR2820350414%3E3.0.CO;2-Z

Single and combination nonhormonal chemotherapy in breast cancer

29 September 2023

7

1 reference

10.1002/1097-0142(197504)35:4<1108::AID-CNCR2820350414>3.0.CO;2-Z

https://api.crossref.org/works/10.1002/1097-0142(197504)35:4%3C1108::AID-CNCR2820350414%3E3.0.CO;2-Z

Some thoughts on experimental models and their clinical correlations.

29 September 2023

8

1 reference

10.1002/1097-0142(197504)35:4<1108::AID-CNCR2820350414>3.0.CO;2-Z

https://api.crossref.org/works/10.1002/1097-0142(197504)35:4%3C1108::AID-CNCR2820350414%3E3.0.CO;2-Z

Superiority of adriamycin over oral nitrosoureas in patients with advanced breast carcinoma.A southwest cancer chemotherapy study group study

29 September 2023

12

1 reference

10.1002/1097-0142(197504)35:4<1108::AID-CNCR2820350414>3.0.CO;2-Z

https://api.crossref.org/works/10.1002/1097-0142(197504)35:4%3C1108::AID-CNCR2820350414%3E3.0.CO;2-Z

Phase II evaluation of adriamycin in human neoplasia

29 September 2023

16

1 reference

10.1002/1097-0142(197504)35:4<1108::AID-CNCR2820350414>3.0.CO;2-Z

https://api.crossref.org/works/10.1002/1097-0142(197504)35:4%3C1108::AID-CNCR2820350414%3E3.0.CO;2-Z

Disseminated breast carcinoma. Treatment with combination chemotherapy

29 September 2023

19

1 reference

10.1002/1097-0142(197504)35:4<1108::AID-CNCR2820350414>3.0.CO;2-Z

https://api.crossref.org/works/10.1002/1097-0142(197504)35:4%3C1108::AID-CNCR2820350414%3E3.0.CO;2-Z

29 September 2023

Identifiers

10.1002/1097-0142(197504)35:4<1108::AID-CNCR2820350414>3.0.CO;2-Z

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1116104%20AND%20SRC:MED&resulttype=core&format=json

31 August 2019

1 reference